Leadership1 distinct publisher3 min readUpdated
The clauses worth arguing about are the ones that reappear in your Series B. Most founders spend their negotiating budget on language that stops mattering the day the round closes.
The Board Room · Leadership desk
Compiled by The Board RoomSomething wrong?How this is made
One question does the sorting: whether you will still be living with the term in three years, or whether it bites only in a single scenario you can price this week [1].
Liquidation preference is the clean case. Cooley ranks it as usually the next most important business issue after valuation, and notes that it is often mistaken for a legal point and glossed over [8][9]. What earns it a slot is not the drafting, it is the replication: terms agreed at Series A often carry over into Series B and beyond [11]. A clause that copies itself into your next two rounds has stopped being a clause and become a default setting.
The same guidance hands founders a counter that mostly goes unused. Because Series A terms travel forward and can end up working against the Series A investors themselves later on, that carry-over is available as leverage to keep a term out in the first place [12]. The person across the table has a reason to agree with you.
Before any markup, model expected exit values so you know the dollar gap between the preference formulas on offer [10]. Do that and the sorting largely happens on its own: a provision that moves the founder outcome by a rounding error at every exit value you consider does not deserve an email, let alone two passes of redlines.
Valuation takes the first slot, and Cooley's warning there is mechanical rather than philosophical: understand what including the option pool inside the fully diluted pre-money number does to your side of the cap table [5][6]. The guidance also states the trade plainly, that a lower valuation from a great investor may be better than a higher one from a bad investor [7].
Which leaves one slot [16]. The material names valuation and preference, says the list is not exhaustive, and points to advisors and other published resources for the rest [14][15]. So the third is yours to nominate, and the test is the same: what governs who can block a decision, and what happens when the company is sold. A term that fails that test is a line on an invoice.
The reason speed here is not surrender is structural. Cooley draws the contrast with M&A, where parties float red herring issues to pull attention away from the real ones, and points out that an investment is different because the two sides have to work together intensely after closing [13]. The negotiation is a sample of your judgment taken before you become colleagues. Sign everything and you lose credibility with the investor [2]. Contest everything and you look inexperienced while both sides lose the thread [3].
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
Cooley's "Negotiating Term Sheets" guidance advises founders to follow a "Rule of 3": focus negotiating energy on about three issues, resolve the important points early, close as quickly as possible, and get back to growing the company. The author says that in their experience there are most often about three issues in any term sheet worth arguing about.
Cooley warns that if a founder accepts the term sheet "as is" and does not negotiate the important issues, the founder may lose credibility with the VC, and that how a founder acts during this phase can significantly affect the relationship going forward.
Cooley warns that arguing endlessly about every point, many of which are largely not material, makes a founder look inexperienced and causes the parties to lose focus on what really matters.
Cooley says founders who get bogged down on smaller term sheet points waste time and legal fees.
Cooley describes valuation/dilution as obviously one of the most important issues in a term sheet, although not a legal one.
Cooley tells founders to make sure they understand the effect of including the option pool in the fully diluted pre-money valuation.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One primary advisory source, experiential rather than measured
All claims trace to a single law-firm guidance article that is authoritative about its own recommendations and internally consistent, but the substantive assertions are practitioner judgement ('in my experience there are most often about 3 issues') with no dataset, sample or citation, and no second source in the cluster to corroborate the rankings of valuation and liquidation preference or the carry-forward leverage argument.
No adoption signal in supplied material
The cluster contains no release, deployment, usage disclosure, pricing or benchmark evidence, and no data on how widely the Rule of 3 or these term ranking priorities are actually followed in negotiated rounds. Nothing in the supplied source supports an adoption measurement.
Slightly overstated: an anecdotal rule presented as a rule
The framing is restrained for the genre — no product, no metrics claimed, explicit non-exhaustiveness caveat and a pointer to outside resources — so the gap is small. It is positive rather than zero because a numeric-sounding 'Rule of 3' generalises from one practitioner's experience without evidence, and because the article's own ranking already fills two of those three slots, which understates how much of a term sheet the reader is being told to sign unexamined.
Law-firm founder-education content with clear business-development interest
The publisher is a startup law firm's own guidance channel. The advice repeatedly routes readers to professional advisors and an experienced startup lawyer, and cites the firm's own venture financing trends report, all of which serve client acquisition. The counterweight is that the substantive advice reduces legal spend by discouraging protracted negotiation, and that no disclosure of this interest appears in the text.
Claims accurately represent the source, but the source stands alone
Confidence in what the publisher said is high: each canonical claim maps cleanly onto explicit sentences in the article. Confidence that the guidance generalises is moderate at best, because there is one publisher, no independent corroboration, no adoption evidence, and the supplied body ends mid-sentence before the protective provisions discussion concludes.
invest
The Lakers at $12.5B reads better as a deduction than as a basketball team1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 23, 2026